â– EMBRYOLOGY: The Ligamentum Venosum is a thin, fibrous cord situated in a deep fissure on the visceral surface of the left lobe of the liver.
â– THE SHUNT Remnant (Ductus Venosus):
- During intrauterine life, oxygenated blood from the placenta travels through the left umbilical vein toward the fetal heart.
- To bypass the highly resistant, capillary-dense immature fetal liver, the majority of this blood is redirected through a vascular shunt called the Ductus Venosus, which drains directly into the Inferior Vena Cava (IVC).
- Postnatal Event: At birth, placental separation plunges PGE2 levels, and the ductus venosus closes and collapses, obliterating within weeks.
â– IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
â– CLINICAL REGISTRY INSIGHTS:
Patient registry reviews depict high clinical validity in diverse populations, indicating highly correlated trends of symptom development and treatment responsiveness.
[HY-BOARD-1016]
🌟 Dynamic Clinical Key:
The obliterated Ductus Venosus forms the Ligamentum Venosum in adults. If this shunt fails to close postnatally (Patent Ductus Venosus), portal blood bypasses the liver filters (Portosystemic Shunt), causing hepatic encephalopathy and hyperammonemia in infants. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Assess demographic representation when applying trial results to real-world patients.